Arecor Therapeutics PLC
LSE:AREC
Cash Flow Statement
Cash Flow Statement
Arecor Therapeutics PLC
Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | ||
---|---|---|---|---|---|
Operating Cash Flow | |||||
Net Income |
(7)
|
(9)
|
(11)
|
(10)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
1
|
|
Other Non-Cash Items |
1
|
1
|
0
|
0
|
|
Cash Taxes Paid |
(1)
|
0
|
(1)
|
(1)
|
|
Cash Interest Paid |
0
|
0
|
0
|
0
|
|
Change in Working Capital |
0
|
(0)
|
(1)
|
(1)
|
|
Cash from Operating Activities |
(5)
N/A
|
(8)
-48%
|
(11)
-34%
|
(11)
-1%
|
|
Investing Cash Flow | |||||
Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
|
Other Items |
0
|
0
|
(8)
|
(1)
|
|
Cash from Investing Activities |
(0)
N/A
|
(0)
-122%
|
(8)
-5 202%
|
(1)
+83%
|
|
Financing Cash Flow | |||||
Net Issuance of Common Stock |
20
|
0
|
6
|
6
|
|
Net Issuance of Debt |
2
|
(0)
|
(0)
|
(1)
|
|
Other |
(1)
|
(0)
|
(0)
|
(0)
|
|
Cash from Financing Activities |
21
N/A
|
(0)
N/A
|
5
N/A
|
5
-1%
|
|
Change in Cash | |||||
Effect of Foreign Exchange Rates |
0
|
(0)
|
0
|
0
|
|
Net Change in Cash |
15
N/A
|
(8)
N/A
|
(14)
-61%
|
(7)
+48%
|
|
Free Cash Flow | |||||
Free Cash Flow |
(6)
N/A
|
(8)
-49%
|
(11)
-35%
|
(11)
0%
|